Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07311148 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 30, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This phase 2 study in China will evaluate the immunogenicity and safety of the Recombinant Zoster Vaccine, LYB004 in adults aged 40 years and older.
Trial Details
NCT Number NCT07311148
Lead Sponsor Guangzhou Patronus Biotech Co., Ltd.
Conditions
(from sponsor)		 Herpes Zoster (HZ), Shingles, VZV, Recombinant Zoster Vaccine
Related terms Chickenpox, Herpes Zoster
Enrollment 840 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov